Upexi Inc
UPXI
View Detailed Chart
6.040USD
-0.290-4.58%
Close 09/05, 16:00（ET）Quotes delayed by 15 min
8.64MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-4.58%
5 Days
-16.46%
1 Month
+14.61%
6 Months
+142.57%
Year to Date
+72.07%
1 Year
+48.40%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-05Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
15.500
Target Price
+144.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Growing
The company is in a growing phase, with the latest annual income totaling USD 26.00M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1026.14.
Overvalued
The company’s latest PE is -0.01, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 10.18M shares, increasing 42.84% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 500.84K shares of this stock.
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Ticker SymbolUPXI
CompanyUpexi Inc
CEO
Websitehttps://upexi.com/
Related Instruments
+1.08%
+1.16%
+0.51%
-2.21%
-1.92%
-1.09%
+3.56%
+1.15%
-1.08%
+0.65%
+0.47%
-0.01%
-0.78%
+0.85%
-1.24%
-2.80%
+3.40%
-0.40%
+0.40%
+3.82%
